Nature GeneticsGenomicsPeer-reviewed journal article
Characterizing the molecular regulation of inhibitory immune checkpoints with multi-modal single-cell screens
Efthymia PapalexiiD, Eleni P. MimitouiD, Andrew ButleriD, Samantha D. Foster, Bernadette Bracken, William M. MauckiD, Hans‐Hermann WesselsiD, Yuhan HaoiD, Bertrand Z. YeungiD, Peter SmibertiD, Rahul SatijaiD
Abstract
The expression of inhibitory immune checkpoint molecules such as PD-L1 is frequently observed in human cancers and can lead to the suppression of T cell-mediated immune responses. Here we apply ECCITE-seq, a technology which combines pooled CRISPR screens with single-cell mRNA and surface protein measurements, to explore the molecular networks that regulate PD-L1 expression. We also develop a computational framework, mixscape, that substantially improves the signal-to-noise ratio in single-cell perturbation screens by identifying and removing confounding sources of variation. Applying these tools, we identify and validate regulators of PD-L1, and leverage our multi-modal data to identify both transcriptional and post-transcriptional modes of regulation. In particular, we discover that the kelch-like protein KEAP1 and the transcriptional activator NRF2, mediate levels of PD-L1 upregulation after IFN{gamma} stimulation. Our results identify a novel mechanism for the regulation of immune checkpoints and present a powerful analytical framework for the analysis of multi-modal single-cell perturbation screens.
- organism: human
- assay: scRNA-seq
- assay: CITE-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
- approach: statistical model
- Citations
- 237
- FWCI
- 14.64
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CRISPR screens establish regulatory maps of immunosuppressive surface molecules in cancer
Robert Kalis, Sumit Deswal, … Johannes A. Zuber·bioRxiv·Mar 11, 2026
- Multi-modal pooled Perturb-CITE-Seq screens in patient models define novel mechanisms of cancer immune evasion
Chris J. Frangieh, Johannes C. Melms, … Benjamin Izar·Nature GeneticsPeer-reviewed·Mar 1, 2021
- CRISPR activation screening identifies VGLL3 and GATA2 as transcriptional regulators of PD-L1
R. H. Wijdeven, B. Cabukusta, … J. J. Neefjes·bioRxiv·Aug 18, 2021
- Paired CRISPR screens to map gene regulation in cis and trans
Xinhe Xue, Zoran Z. Gajic, … Neville E. Sanjana·bioRxiv·Nov 27, 2024
- OX40 agonism enhances efficacy of PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum
G. Beyrend, T. C. van der Sluis, … R. Arens·bioRxiv·Dec 24, 2021
- Tumor intrinsic regulation of PD-L1 and of interferon Type I via an SLC25A1-driven mitochondrial pathway, influences the anti-tumor immune response
Rami Mosaoa, Maha Moussa, … Maria Laura Avantaggiati·bioRxiv·Sep 20, 2025